Table 1. Comparison of biomarkers examined in this study of colon cancer patients.
| Anti-FIRs antibodies | Anti-p53 antibodies | CEA | CA19-9 | |
|---|---|---|---|---|
| sensitivity(%) | 78 | 30 | 78 | 62 |
| specificity(%) | 78 | 91 | 78 | 62 |
| Positive Predictive Value(%) | 87 | 87 | 88 | 77 |
| Negative Predictive Value(%) | 63 | 40 | 63 | 44 |